BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22749392)

  • 1. Synthesis and biological evaluation of novel (E) stilbene-based antitumor agents.
    Csuk R; Albert S; Siewert B; Schwarz S
    Eur J Med Chem; 2012 Aug; 54():669-78. PubMed ID: 22749392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antitumor activity of ring A modified glycyrrhetinic acid derivatives.
    Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
    Eur J Med Chem; 2011 Nov; 46(11):5356-69. PubMed ID: 21959232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alkylidene branched lupane derivatives: synthesis and antitumor activity.
    Csuk R; Stark S; Nitsche C; Barthel A; Siewert B
    Eur J Med Chem; 2012 Jul; 53():337-45. PubMed ID: 22578785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antitumor evaluation, and apoptosis-inducing activity of hydroxylated (E)-stilbenes.
    Lion CJ; Matthews CS; Stevens MF; Westwell AD
    J Med Chem; 2005 Feb; 48(4):1292-5. PubMed ID: 15715501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antitumour activity of glycyrrhetinic acid derivatives.
    Schwarz S; Csuk R
    Bioorg Med Chem; 2010 Nov; 18(21):7458-74. PubMed ID: 20932766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic betulin-derived hydroxypropargylamines trigger apoptosis.
    Csuk R; Sczepek R; Siewert B; Nitsche C
    Bioorg Med Chem; 2013 Jan; 21(2):425-35. PubMed ID: 23245801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and anticancer activity of N-substituted 2-arylquinazolinones bearing trans-stilbene scaffold.
    Mahdavi M; Pedrood K; Safavi M; Saeedi M; Pordeli M; Ardestani SK; Emami S; Adib M; Foroumadi A; Shafiee A
    Eur J Med Chem; 2015 May; 95():492-9. PubMed ID: 25847767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 4-arylcoumarin analogues of combretastatins.
    Bailly C; Bal C; Barbier P; Combes S; Finet JP; Hildebrand MP; Peyrot V; Wattez N
    J Med Chem; 2003 Dec; 46(25):5437-44. PubMed ID: 14640552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.
    Roberti M; Pizzirani D; Simoni D; Rondanin R; Baruchello R; Bonora C; Buscemi F; Grimaudo S; Tolomeo M
    J Med Chem; 2003 Jul; 46(16):3546-54. PubMed ID: 12877593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic agents. 445. Synthesis and evaluation of structural modifications of (Z)- and (E)-combretastatin A-41.
    Pettit GR; Rhodes MR; Herald DL; Hamel E; Schmidt JM; Pettit RK
    J Med Chem; 2005 Jun; 48(12):4087-99. PubMed ID: 15943482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of cytotoxic properties of stilbene-based resveratrol analogs.
    de Lima DP; Rotta R; Beatriz A; Marques MR; Montenegro RC; Vasconcellos MC; Pessoa C; de Moraes MO; Costa-Lotufo LV; Frankland Sawaya AC; Eberlin MN
    Eur J Med Chem; 2009 Feb; 44(2):701-7. PubMed ID: 18586355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells.
    Minutolo F; Sala G; Bagnacani A; Bertini S; Carboni I; Placanica G; Prota G; Rapposelli S; Sacchi N; Macchia M; Ghidoni R
    J Med Chem; 2005 Nov; 48(22):6783-6. PubMed ID: 16250636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel stilbene-based antitumor agents.
    Simoni D; Invidiata FP; Eleopra M; Marchetti P; Rondanin R; Baruchello R; Grisolia G; Tripathi A; Kellogg GE; Durrant D; Lee RM
    Bioorg Med Chem; 2009 Jan; 17(2):512-22. PubMed ID: 19117761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halogenated flavanones as potential apoptosis-inducing agents: synthesis and biological activity evaluation.
    Safavi M; Esmati N; Ardestani SK; Emami S; Ajdari S; Davoodi J; Shafiee A; Foroumadi A
    Eur J Med Chem; 2012 Dec; 58():573-80. PubMed ID: 23174316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conversions at C-30 of glycyrrhetinic acid and their impact on antitumor activity.
    Csuk R; Schwarz S; Siewert B; Kluge R; Ströhl D
    Arch Pharm (Weinheim); 2012 Mar; 345(3):223-30. PubMed ID: 21997717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineoplastic agents. 578. Synthesis of stilstatins 1 and 2 and their water-soluble prodrugs.
    Pettit GR; Thornhill A; Melody N; Knight JC
    J Nat Prod; 2009 Mar; 72(3):380-8. PubMed ID: 19228038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
    Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
    J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and antitumor-evaluation of cyclopropyl-containing combretastatin analogs.
    Fürst R; Zupkó I; Berényi A; Ecker GF; Rinner U
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6948-51. PubMed ID: 19879758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.
    Pettit GR; Anderson CR; Herald DL; Jung MK; Lee DJ; Hamel E; Pettit RK
    J Med Chem; 2003 Feb; 46(4):525-31. PubMed ID: 12570374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A "natural" approach: synthesis and cytoxicity of monodesmosidic glycyrrhetinic acid glycosides.
    Schwarz S; Siewert B; Xavier NM; Jesus AR; Rauter AP; Csuk R
    Eur J Med Chem; 2014 Jan; 72():78-83. PubMed ID: 24361520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.